The present invention relates to a self-injection device. More particularly, the present invention relates to a self-injection device having a compressible reservoir. Still more particularly, the present invention relates to a self-injection device having an adjustable injection depth to allow an intradermal, junctional or subcutaneous injection, as well as allowing the self-injection device to be filled with a medicament. Still more particularly, the self-injection device has a passive safety mechanism to prevent accidental needle sticks.
Syringes are used to inject medicaments into tissue areas, such as the subcutaneous tissue layer, the intradermal tissue layer or the junctional area between the intradermal and subcutaneous tissue layers. However, existing syringes are only able to deliver medicament to one of these tissue layers. Thus, a separate inventory of syringes is required for delivering medicament to each of the intradermal, junctional and subcutaneous tissue layers, thereby increasing inventory and manufacturing costs.
Accordingly, a need exists for a syringe adapted to deliver medicament to any of the intradermal, subcutaneous and junctional tissue layers.
Additionally, a need exists for incorporation of safety mechanisms into such a device to prevent the spread of bacterial and viral pathogens via a needle stick or other accident.
The self-injection device according to an exemplary embodiment of the present invention has an adjustable injection depth, thereby allowing intradermal, junctional or subcutaneous injections with the same self-injection device.
In accordance with an exemplary embodiment of the present invention, a self-injection device includes a housing, and a needle connected to the housing. The needle is movable between a first position in which a proximal end of the needle is disposed within the housing and a second position in which the proximal end of the needle is disposed outside of the housing. A compressible reservoir is connected to the housing and in fluid communication with the needle such that compressing the reservoir delivers medicament from the reservoir to the needle and moves the needle from the first position to the second position.
In accordance with another exemplary embodiment of the present invention, a self-injection device includes a housing, and a needle connected to the housing. The needle is movable between a first position in which the needle is disposed entirely within the housing and a second position in which a proximal end of the needle is disposed outside of the housing. A platform is disposed within the housing about which the housing is rotatable between a plurality of positions. Each of the positions corresponds to a different distance the needle is moved to the second position during an injection.
In accordance with another exemplary embodiment of the present invention, a method of administering a medicament with an injection device is provided. The device is placed on the site where the medicament is to be delivered. A reservoir, which is connected to the housing and to a needle disposed in the housing, is depressed to inject the needle into the site and to deliver the medicament stored in the reservoir from the reservoir, through the needle and into the site. The desired injection depth is selected by rotating an upper housing of the housing relative to a lower housing.
The above benefits and other advantages of the various embodiments of the present invention will be more apparent from the following detailed description of exemplary embodiments of the present invention and from the accompanying drawing figures, in which:
Throughout the drawings, like reference numbers will be understood to refer to like parts, components and structures.
A self-injection device 101 according to an exemplary embodiment of the present invention, as shown in
The housing 111 includes an upper housing 131 and a lower housing 141, as shown in
The upper housing 131 has a base 133 and a wall 135 extending substantially perpendicularly from an outer edge thereof. A free end of the wall 135 has a plurality of inwardly extending tabs 137. Cut-out portions 138 are formed in the wall 135 adjacent the tabs 137 to facilitate the flexibility of the tabs. A projection 139 extends outwardly from an inner surface 134 of the base 133 of the upper housing 131. An opening 138 extends through the entire length of the projection 139. A first tab (not shown) and a second tab 136 extend downwardly from the inner surface 134 and are diametrically opposed with respect to the projection 139. First and second flanges 130 and 132 extend downwardly from the inner surface 134 and are diametrically opposed with respect to the projection 139. Preferably, the first and second flanges 130 and 132 are substantially L-shaped and are disposed radially outwardly of the first and second tabs 136 and 138 relative to the projection 139. A window 107 is formed in the base 133 of the upper housing 131. The upper housing preferably has an outer diameter of approximately 31 millimeters.
The lower housing 141 has a base 143 and a wall 145 extending substantially perpendicularly from an outer edge thereof, as shown in
An adhesive backing may be disposed on the outer surface of the base 143 of the lower housing 141 to substantially prevent movement of the self-injection device 101 when placed on a skin surface to perform an injection. The adhesive backing may also assist in immobilizing, fixing, stretching or spreading the skin to facilitate the injection.
A series 151 of steps 153, 155, 157 and 159 extend upwardly from an inner surface 144 of the base 143, as shown in
The skin is made up of three layers: epidermis, dermis and subcutaneous layers. The epidermis is the outermost layer of the skin, with the dermis layer underlying the epidermis, and the subcutaneous layer underlying the dermis. An intradermal injection is made in the dermis layer, and requires an injection depth of approximately 1 mm. A junctional injection is made in the junction between the dermis and the subcutaneous layers, and requires an injection depth of approximately 2 mm. A subcutaneous injection is made in the subcutaneous layer, and requires an injection depth of approximately 4 mm.
A spring 161 is disposed inside the housing 111, as shown in
A platform 171 is disposed adjacent the inner surface 134 of the base 133 of the upper housing and is secured thereto by the first and second flanges 130 and 132, as shown in
A compressible reservoir 121 is connected to the upper housing 131, as shown in
The needle 103 is fixedly connected to the base 133 of the upper housing 131, as shown in
The septum 181 is connected to an inner surface 144 and to the cavity 150 of the base 143 of the lower housing 141, as shown in
The self-injection device 101 may be pre-filled or filled by the user. The procedure for filling the self-injection device 101 with medicament is substantially similar to injecting medicament into a site, and is described hereafter.
The self-injection device is shown in the locked position in
The inner diameter of the upper housing 131 is larger then the outer diameter of the lower housing 141, as shown in
The self-injection device is shown in a position corresponding to an intradermal injection in
The needle 103 is fixed to and moves with the upper housing 131. The proximal end 104 of the needle 103 passes through the septum 181 and through the opening 149 in the cavity 150 of the base 143 of the lower housing 141. Medicament stored in the cavity 123 of the reservoir 121 enters the distal end 105 of the needle 103, travels through the needle 103 and into the injection site. Upon releasing the reservoir 123, the compressed spring 161 expands. This action withdraws the needle 103 from the injection site and through the opening 149 such that the proximal end 104 of the needle 103 is again disposed within the septum 181. Preferably, the self-injection device 101 is discarded after being used for an injection. The proximal end 104 of the needle 103 being disposed in the septum 181 prevents an accidental needle stick following the injection.
As described in the preceding paragraph, the upper housing 131 is rotatable to positions corresponding to a junctional injection (
In the subcutaneous injection position, the platform indicator may be the numeral “4” (
To fill an empty reservoir, the process is similar to performing a subcutaneous injection. The upper housing 131 is rotated to the position corresponding to the subcutaneous injection, as shown in
The compact size of the self-injection device 101 makes it user-friendly, particularly in view of being operable with one hand. Each component of the self-injection device 101 is multifunctional, thereby reducing the number of parts required for assembly. Furthermore, as noted above, after performing an injection the upper housing 131 is rotated back to the lock position, thereby preventing accidental needle sticks and converting the self-injection device 101 into its own self-contained “sharps collector.”
Furthermore, the self-injection device 101 incorporates a safety mechanism to prevent the spread of bacterial and viral pathogens via a needle stick or other accident. As noted above, upon release of the reservoir 121 the needle 103 is withdrawn back into the housing 111, as shown in
In another exemplary embodiment of the present invention, as shown in
In another exemplary embodiment, as shown in
A self-injection device according to exemplary embodiments of the present invention provides a safe and user-friendly push-button self-injection device, which allows for injection of a medicament, such as a vaccine or insulin. The self-injection device includes passive retraction of the needle to prevent the spread of bacterial and viral pathogens via a needle stick or other accident. The desired injection depth is selected and the self-injection device is placed on the patient's skin. The compressible reservoir is depressed, thereby injecting the needle into the skin and administering the medicament. Alternatively, a reservoir fill mode may be selected, and the self-injection device is placed over a vial containing a medicament to draw the medicament into the compressible reservoir. Releasing the compressible reservoir automatically withdraws the needle, thereby providing a safe self-injection device.
While exemplary embodiments have been chosen to illustrate the invention, it will be understood by those skilled in the art that various changes and modifications may be made therein without departing from the scope of the invention as defined in the appended claims and their equivalents.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2009/005148 | 9/15/2009 | WO | 00 | 5/25/2012 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2011/034516 | 3/24/2011 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1288174 | Pittenger | Dec 1918 | A |
2667165 | Smith | Jan 1954 | A |
2874694 | Blackman | Feb 1959 | A |
4282986 | af Ekenstam | Aug 1981 | A |
4522622 | Peery | Jun 1985 | A |
4548601 | Lary | Oct 1985 | A |
4883473 | Thomas | Nov 1989 | A |
4886499 | Cirelli | Dec 1989 | A |
4894054 | Miskinyar | Jan 1990 | A |
4955871 | Thomas | Sep 1990 | A |
5019048 | Margolin | May 1991 | A |
5248303 | Margolin | Sep 1993 | A |
5478315 | Brothers et al. | Dec 1995 | A |
5527287 | Miskinyar | Jun 1996 | A |
5860957 | Jacobsen | Jan 1999 | A |
5944700 | Nguyen | Aug 1999 | A |
6086562 | Jacobsen et al. | Jul 2000 | A |
7252651 | Haider | Aug 2007 | B2 |
7297136 | Wyrick | Nov 2007 | B2 |
20020042589 | Marsoner | Apr 2002 | A1 |
20040116847 | Wall | Jun 2004 | A1 |
20040182471 | Hansen | Sep 2004 | A1 |
20050187519 | Harris | Aug 2005 | A1 |
20070016149 | Hunn | Jan 2007 | A1 |
20070016150 | Barkhahn | Jan 2007 | A1 |
20070191780 | Modi | Aug 2007 | A1 |
20100137831 | Tsals | Jun 2010 | A1 |
20120136300 | Schoonmaker et al. | May 2012 | A1 |
Number | Date | Country |
---|---|---|
0258073 | Jun 1987 | EP |
0 749 758 | Dec 1996 | EP |
0 904 790 | Mar 1999 | EP |
770341 | Mar 1957 | GB |
9-10308 | Jan 1997 | JP |
9-504974 | May 1997 | JP |
9-285539 | Nov 1997 | JP |
2001-9032 | Jan 2001 | JP |
2005-21291 | Jan 2005 | JP |
2005-538773 | Dec 2005 | JP |
2009-526575 | Jul 2009 | JP |
WO 9513833 | May 1995 | WO |
WO 0204053 | Jan 2002 | WO |
WO 2008083209 | Jul 2008 | WO |
WO 2008083209 | Jul 2008 | WO |
WO 2009098502 | Aug 2009 | WO |
Entry |
---|
Japanese Office Action dated Aug. 20, 2013 issued by the Japanese Patent Office in counterpart Japanese Application No. 2012-529720. |
Supplementary Partial European Search Report, Mailed Jul. 30, 2014, 9 pages. |
Number | Date | Country | |
---|---|---|---|
20120245558 A1 | Sep 2012 | US |